Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Pharmaceutical Research
|
March 27, 2025
PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric Populations
Fang Wu, Eleftheria Tsakalozou, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics
|
November 22, 2021
Model-Informed Drug Development Approaches to Assist New Drug Development in the COVID-19 Pandemic
Ye Xiong, Jianghong Fan, Eliford Kitabi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 30, 2018
Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach
Bart Hens, Marival Bermejo, Yasuhiro Tsume, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Gastroenterology
|
December 25, 2013
Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol
Edwin C Y Chow, Lilia Magomedova, Holly P Quach, et al.
Cell Death & Disease
|
May 19, 2021
Nicotine aggravates vascular adiponectin resistance via ubiquitin-mediated adiponectin receptor degradation in diabetic Apolipoprotein E knockout mouse
Jia Gao, Jianghong Fan, Zhijun Meng, et al.
Pharmaceutical Research
|
June 4, 2025
Assessing Impact of Food on Oral Drug Bioequivalence Supporting ICH M13 A with the Advancements of Physiologically Based Pharmacokinetic Modeling
Arindom Pal, Khondoker Alam, Ethan Stier, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 19, 2022
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
Fang Wu, Youssef Mousa, Kimberly Raines, et al.
The AAPS Journal
|
May 22, 2019
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension
Maxime Le Merdy, Jianghong Fan, Michael B Bolger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Pharmaceutical Research
|
March 27, 2025
PBPK Modeling to Support Bioavailability and Bioequivalence Assessment in Pediatric Populations
Fang Wu, Eleftheria Tsakalozou, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics
|
November 22, 2021
Model-Informed Drug Development Approaches to Assist New Drug Development in the COVID-19 Pandemic
Ye Xiong, Jianghong Fan, Eliford Kitabi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 30, 2018
Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach
Bart Hens, Marival Bermejo, Yasuhiro Tsume, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Gastroenterology
|
December 25, 2013
Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol
Edwin C Y Chow, Lilia Magomedova, Holly P Quach, et al.
Cell Death & Disease
|
May 19, 2021
Nicotine aggravates vascular adiponectin resistance via ubiquitin-mediated adiponectin receptor degradation in diabetic Apolipoprotein E knockout mouse
Jia Gao, Jianghong Fan, Zhijun Meng, et al.
Pharmaceutical Research
|
June 4, 2025
Assessing Impact of Food on Oral Drug Bioequivalence Supporting ICH M13 A with the Advancements of Physiologically Based Pharmacokinetic Modeling
Arindom Pal, Khondoker Alam, Ethan Stier, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 19, 2022
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report
Fang Wu, Youssef Mousa, Kimberly Raines, et al.
The AAPS Journal
|
May 22, 2019
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension
Maxime Le Merdy, Jianghong Fan, Michael B Bolger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, et al.
Page
of 5